News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
09.14.2022Dr. Channa Amarasekera discusses how the innovative Gay and Bisexual Men’s Urology Program has personalized treatment for LGBT+ Community.
09.08.2022In this video, Neil Mistry, MD, MPH, and Adam B. Murphy, MD, MBA, MSCI, discuss future research and the take-home message from the abstract, “West-African ancestry can aid prediction of high-grade prostate cancer in Black-tailored risk calculator,” which was presented at the North Central Section of the AUA Annual Meeting in Chicago, Illinois.
07.28.2022Two years after his treatment with Dr. Schaeffer, Dr. DeGould is healthy, grateful, and eager to give back to help future patients with cancer.
07.19.2022American men are sicker and die earlier than men living in other developed nations, according to a new report from the Commonwealth Fund, a non-profit organization focusing on public health issues. Dr. Nelson Bennett, MD, looks at the statistics.
07.12.2022William J. Catalona, MD, explains how the approach of active surveillance in prostate cancer emerged alongside the advent of PSA screening.
07.11.2022Alicia Morgans and Ashley Ross discuss Decipher testing, both Decipher Biopsy and Decipher for prostatectomy specimens, and how to integrate these tests into standard clinical practice.
07.08.2022In this video, Edward M. Schaeffer, MD, PHD, discusses the National Comprehensive Cancer Network’s process for updating its guidelines for prostate cancer.
06.27.2022Joshua J. Meeks, MD, PhD, recaps several presentations on bladder cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
06.25.2022William Catalona, MD, explains the evolution of his views regarding active surveillance in men with low-risk prostate cancer.- 06.24.2022
Ashley E. Ross, MD, PhD, recaps several presentations on prostate cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
06.17.2022Robert E. Brannigan, MD, vice-chair of Clinical Urology, discusses which men with infertility issues should receive genetic testing.
06.01.2022In an interview with Targeted Oncology, William J. Catalona, MD, reviews the history of active surveillance in the prostate cancer space and how the practice has become more widespread in the United States.
05.23.2022Matthew S. Lee, MD, discusses the background and notable findings from the study, “Outcomes after holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy: experience from a large academic medical center,” which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
05.20.2022Joshua Halpern, MD, discusses the goals and outcomes of the study, “Elevated follicle stimulating hormone (FSH) predicts decline in semen parameters among men with normal index semen analysis,” which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
05.19.2022Dr. Amy Krambeck argues in favor of achieving stone-free status in all patients undergoing PCNL.
05.16.2022At the 2022 American Urological Association meeting, Dr. Mohammad Siddiqui and colleagues presented the results of their study investigating whether capsular ‘abutment’ on pre-operative mpMRI is an indication of prostate pathology in cancerous forms.- 05.15.2022William Catalona, MD, a panel member at the 2022 annual American Urological Association (AUA) meeting, evaluates data indicating that the number of men with prostate cancer who opted for active surveillance (AS) doubled nationally between 2014 and 2021.
05.14.2022At the 2022 American Urological Association meeting, Nelson E. Bennett, MD, moderated a plenary session which analyzed the benefits and disadvantages of telemedicine in sexual medicine.
05.14.2022At the 2022 American Urological Association meeting, Dr. Huang and Justin Dubin, MD, investigated the quality of information for testosterone therapy on social media channels with their respective studies.
- 05.14.2022
Adam B. Murphy, MD, MBA, MSCI, discusses the background and rationale for the study, “Vitamin D has a stronger impact on prostate tumor gene expression in Black men,” which he presented at the 2022 American Urological Association annual meeting in New Orleans.
05.13.2022Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
05.06.2022Amy Krambeck, MD, highlights 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting.
05.06.2022Dr. Justin Dubin, a Urology fellow specializing in male infertility and sexual medicine, provides insight into the association between getting the COVID infection and erectile dysfunction.
- 05.04.2022
Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year if receiving external beam radiation with a brachytherapy boost, according to a study co-authored by Ashley Ross, MD, PhD.
05.03.2022Urinary incontinence can plague men as they age, but a new study suggests it may be more than just a bothersome condition and might actually be a harbinger of early death. Dr. Anthony Schaeffer explains why he thinks the results may be statistically significant, but not clinically significant.
05.03.2022This year's grant recipient includes Stephanie J. Kielb, MD, for her work with the International Organization for Women & Development (IOWD).
05.01.2022Channa Amarasekera, MD, discusses how the Northwestern Medicine Gay and Bisexual Men's Urology Program is helping heal a community that typically gets overlooked during their urological care.- 04.22.2022Channa Amarasekera, MD, discusses the impact of the Gay and Bisexual Men’s Urology Program.
- 04.20.2022
William J. Catalona, MD, explains why he believes the cancer label is necessary.